Incyte Corporation (INCY): Price and Financial Metrics
GET POWR RATINGS... FREE!
INCY POWR Grades
- INCY scores best on the Quality dimension, with a Quality rank ahead of 96.7% of US stocks.
- INCY's strongest trending metric is Stability; it's been moving down over the last 163 days.
- INCY ranks lowest in Momentum; there it ranks in the 9th percentile.
INCY Stock Summary
- INCY has a higher market value than 86.16% of US stocks; more precisely, its current market capitalization is $16,513,782,602.
- For INCY, its debt to operating expenses ratio is greater than that reported by just 6.58% of US equities we're observing.
- In terms of twelve month growth in earnings before interest and taxes, Incyte Corp is reporting a growth rate of -328.01%; that's higher than just 6.06% of US stocks.
- Stocks that are quantitatively similar to INCY, based on their financial statements, market capitalization, and price volatility, are QRVO, SGEN, SIMO, WDC, and SRPT.
- Visit INCY's SEC page to see the company's official filings. To visit the company's web site, go to www.incyte.com.
INCY Valuation Summary
- INCY's price/earnings ratio is 50; this is 36.99% higher than that of the median Healthcare stock.
- Over the past 243 months, INCY's price/earnings ratio has gone up 80.3.
- Over the past 243 months, INCY's EV/EBIT ratio has gone up 86.9.
Below are key valuation metrics over time for INCY.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| INCY | 2021-08-31 | 6.2 | 5.8 | 50.0 | 37.1 |
| INCY | 2021-08-30 | 6.2 | 5.7 | 49.7 | 36.9 |
| INCY | 2021-08-27 | 6.1 | 5.7 | 49.5 | 36.7 |
| INCY | 2021-08-26 | 6.1 | 5.7 | 49.2 | 36.4 |
| INCY | 2021-08-25 | 6.1 | 5.7 | 49.6 | 36.7 |
| INCY | 2021-08-24 | 6.1 | 5.7 | 49.4 | 36.6 |
INCY Growth Metrics
- The 2 year price growth rate now stands at 62.4%.
- The 4 year revenue growth rate now stands at 159.86%.
- Its 3 year price growth rate is now at 5.41%.
The table below shows INCY's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2021-09-30 | 2,912.923 | 741.458 | 534.58 |
| 2021-06-30 | 2,720.579 | 668.475 | 337.638 |
| 2021-03-31 | 2,702.913 | 764.913 | 478.48 |
| 2020-12-31 | 2,666.702 | -124.599 | -295.697 |
| 2020-09-30 | 2,456.582 | -100.302 | -334.542 |
| 2020-06-30 | 2,387.52 | -12.002 | -191.068 |
INCY's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- INCY has a Quality Grade of A, ranking ahead of 95.94% of graded US stocks.
- INCY's asset turnover comes in at 0.76 -- ranking 198th of 563 Business Services stocks.
- TSSI, APDN, and NUAN are the stocks whose asset turnover ratios are most correlated with INCY.
The table below shows INCY's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.760 | 0.951 | 0.546 |
| 2021-06-30 | 0.754 | 0.949 | 0.381 |
| 2021-03-31 | 0.787 | 0.951 | 0.523 |
| 2020-12-31 | 0.831 | 0.951 | -0.231 |
| 2020-09-30 | 0.774 | 0.948 | -0.298 |
| 2020-06-30 | 0.758 | 0.949 | -0.138 |
INCY Price Target
For more insight on analysts targets of INCY, see our INCY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $102.47 | Average Broker Recommendation | 1.56 (Moderate Buy) |
INCY Stock Price Chart Interactive Chart >
INCY Price/Volume Stats
| Current price | $74.79 | 52-week high | $101.47 |
| Prev. close | $74.76 | 52-week low | $61.91 |
| Day low | $74.68 | Volume | 1,820,500 |
| Day high | $76.50 | Avg. volume | 1,823,464 |
| 50-day MA | $69.98 | Dividend yield | N/A |
| 200-day MA | $75.26 | Market Cap | 16.52B |
Incyte Corporation (INCY) Company Bio
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. The company was founded in 1991 and is based in Wilmington, Delaware.
Latest INCY News From Around the Web
Below are the latest news stories about Incyte Corp that investors may wish to consider to help them evaluate INCY as an investment opportunity.
Shikiar Asset Management Inc Buys Warby Parker Inc, Compass Diversified Holdings, RLJ Lodging ...New York, NY, based Investment company Shikiar Asset Management Inc (Current Portfolio) buys Warby Parker Inc, Compass Diversified Holdings, RLJ Lodging Trust, Qurate Retail Inc, Coty Inc, sells Toll Brothers Inc, Zillow Group Inc, Oaktree Capital Group LLC, AT&T Inc, FedEx Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Shikiar Asset Management Inc. |
The past five years for Incyte (NASDAQ:INCY) investors has not been profitableIncyte Corporation ( NASDAQ:INCY ) shareholders should be happy to see the share price up 14% in the last quarter. But... |
Incyte upgraded to Outperform at RBC citing near-term prospectsOn a down day in the market, Incyte Corporation (INCY +0.6%) is trading higher after RBC Capital Markets upgraded the manufacturer of JAKAFI to Outperform from Sector Perform, citing its near-term performance and increasing visibility in the growth narrative. The price target raised to $90 from $78 per share indicates... |
Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY) and Cytokinetics (CYTK)Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte (INCY – Research Report) and Cytokinetics (CYTK – Research Report). Incyte (INCY) In a report released today, Mara Goldstein from Mizuho Securities maintained a Hold rating on Incyte, with a price target of $95.00. The company's shares closed last Friday at $74.88. According to TipRanks. |
Incyte to Report Fourth Quarter and Year-End 2021 Financial ResultsWILMINGTON, Del., January 18, 2022--Incyte to Report Fourth Quarter and Year-End 2021 Financial Results |
INCY Price Returns
| 1-mo | N/A |
| 3-mo | 12.38% |
| 6-mo | -4.13% |
| 1-year | -23.60% |
| 3-year | -6.45% |
| 5-year | -38.14% |
| YTD | 1.89% |
| 2021 | -15.61% |
| 2020 | -0.39% |
| 2019 | 37.32% |
| 2018 | -32.86% |
| 2017 | -5.55% |
Continue Researching INCY
Want to do more research on Incyte Corp's stock and its price? Try the links below:Incyte Corp (INCY) Stock Price | Nasdaq
Incyte Corp (INCY) Stock Quote, History and News - Yahoo Finance
Incyte Corp (INCY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...